{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:16Z","timestamp":1793133796926,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T00:00:00Z","timestamp":1453248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-0803-0","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T16:17:52Z","timestamp":1453306672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Azacitidine-induced cryptogenic organizing pneumonia: a case report and review of the literature"],"prefix":"10.1186","volume":"10","author":[{"given":"Yanal","family":"Alnimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Abuqayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Alrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,20]]},"reference":[{"issue":"8","key":"803_CR1","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/cncr.22570","volume":"109","author":"X Ma","year":"2007","unstructured":"Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109(8):1536\u201342.","journal-title":"Cancer"},{"issue":"6","key":"803_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/1097-0142(19870915)60:6<1385::AID-CNCR2820600637>3.0.CO;2-I","volume":"60","author":"French registry of acute leukemia and myelodysplastic syndromes","year":"1987","unstructured":"French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique. Cancer. 1987;60(6):1385\u201394.","journal-title":"Cancer"},{"issue":"8","key":"803_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/0145-2126(89)90061-1","volume":"13","author":"J Bouchard","year":"1989","unstructured":"Bouchard J. Mechanism of action of 5-AZA-dC: induced DNA hypomethylation does not lead to aberrant gene expression in human leukemic CEM cells. Leuk Res. 1989;13(8):715\u201322.","journal-title":"Leuk Res"},{"issue":"35","key":"803_CR4","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21(35):5483\u201395.","journal-title":"Oncogene"},{"issue":"5","key":"803_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1592\/phco.25.5.765.63579","volume":"25","author":"CD Adams","year":"2005","unstructured":"Adams CD, Szumita PM, Baroletti SA, Lilly CM. Azacitidine-induced interstitial and alveolar fibrosis in a patient with myelodysplastic syndrome. Pharmacotherapy. 2005;25(5):765\u20138.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"803_CR6","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/MJT.0b013e3181e7a526","volume":"19","author":"A Sekhri","year":"2012","unstructured":"Sekhri A, Palaniswamy C, Kurmayagari K, Kalra A, Selvaraj DR. Interstitial lung disease associated with azacitidine use: a case report. Am J Ther. 2012;19(2):e98\u2013e100.","journal-title":"Am J Ther"},{"issue":"11","key":"803_CR7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2169\/internalmedicine.53.1971","volume":"53","author":"J Kuroda","year":"2014","unstructured":"Kuroda J, Shimura Y, Mizutani S, Nagoshi H, Kiyota M, Chinen Y, et al. Azacitidine-associated acute interstitial pneumonitis. Int Med (Tokyo, Japan). 2014;53(11):1165\u20139.","journal-title":"Int Med (Tokyo, Japan)"},{"issue":"12","key":"803_CR8","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1592\/phco.27.12.1759","volume":"27","author":"CN Hueser","year":"2007","unstructured":"Hueser CN, Patel AJ. Azacitidine-associated hyperthermia and interstitial pneumonitis in a patient with myelodysplastic syndrome. Pharmacotherapy. 2007;27(12):1759\u201362.","journal-title":"Pharmacotherapy"},{"issue":"9","key":"803_CR9","first-page":"1263","volume":"54","author":"TS Vasu","year":"2009","unstructured":"Vasu TS, Cavallazzi R, Hirani A, Marik PE. A 64-year-old male with fever and persistent lung infiltrate. Respir Care. 2009;54(9):1263\u20135.","journal-title":"Respir Care"},{"issue":"2","key":"803_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"803_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.0767-3981.2003.00206.x","volume":"18","author":"F Barl\u00e9si","year":"2004","unstructured":"Barl\u00e9si F, Villani P, Doddoli C, Gimenez C, Kleisbauer JP. Gemcitabine-induced severe pulmonary toxicity. Fundam Clin Pharmacol. 2004;18(1):85\u201391.","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"803_CR12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1378\/chest.121.5.1478","volume":"121","author":"KH Choi","year":"2002","unstructured":"Choi KH, Lee HB, Jeong MY, Rhee YK, Chung MJ, Kwak YG, et al. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia. Chest. 2002;121(5):1478\u201385.","journal-title":"Chest"},{"issue":"6","key":"803_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/PL00007654","volume":"177","author":"E Lappi-Blanco","year":"1999","unstructured":"Lappi-Blanco E, Soini Y, P\u00e4\u00e4kk\u00f6 P. Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia. Lung. 1999;177(6):367\u201376.","journal-title":"Lung"},{"issue":"3","key":"803_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0873-2159(15)30036-2","volume":"16","author":"M Aguiar","year":"2010","unstructured":"Aguiar M, Felizardo M, Mendes AC, Moniz D, Sotto-Mayor R, Bugalho de Almeida A. Organising pneumonia \u2013 the experience of an outpatient clinic of a central hospital. Rev Port Pneumol. 2010;16(3):369\u201389.","journal-title":"Rev Port Pneumol"},{"issue":"12","key":"803_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/archinte.1997.00440330057006","volume":"157","author":"RH Lohr","year":"1997","unstructured":"Lohr RH, Boland BJ, Douglas WW, Dockrell DH, Colby TV, Swensen SJ, et al. Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Int Med. 1997;157(12):1323\u20139.","journal-title":"Arch Int Med"},{"issue":"17","key":"803_CR16","first-page":"659","volume":"99","author":"FX Gispert de","year":"1992","unstructured":"de Gispert FX, Prtyz MA, Camacho L, Rovira A, Albasanz JA, Ruiz MJ. Bronchiolitis obliterans associated with organizing pneumonia. Clinico-pathological study of 6 cases. Med Clin. 1992;99(17):659\u201363.","journal-title":"Med Clin"},{"issue":"3","key":"803_CR17","first-page":"167","volume":"29","author":"JH Shi","year":"2006","unstructured":"Shi JH, Xu WB, Liu HR, Zhu YJ, Cao B, Chen Y, et al. Clinicopathologic features of 18 cases of cryptogenic organizing pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2006;29(3):167\u201370.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"2","key":"803_CR18","first-page":"170","volume":"31","author":"G Zuccarini","year":"2014","unstructured":"Zuccarini G, Bocchino M, Assante LR, Rea G, Sanduzzi A. Metformin\/glibenclamide-related interstitial lung disease: a case report. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(2):170\u20133.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-0803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-016-0803-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-0803-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-0803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T04:13:57Z","timestamp":1506140037000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-0803-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,20]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-0803-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,20]]},"article-number":"15"}}